open access to scientific and medical research

A part of Taylor & Francis Group

Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Noteworthy comment: This is the first report studying the two major primary mutations and the main resistance mutation of EGFR that are the most important companion diagnostic biomarkers for lung cancer targeted therapeutics.

Highly-accessed

Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

Total article views		HTML views	PDF downloads	Totals
16,203	Dovepress*	14,092+	2,028	16,120
	PubMed Central*	2,111	749	2,860
	Totals	16,203	2,777	18,980
*Since 22 June 2015 +Since July 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
2	1	0	0	0	1

View citations on PubMed and Google Scholar